Almanac 2013: cardiac arrhythmias and pacing (Q38125860)

29 August 2017

title

Almanac 2013: cardiac arrhythmias and pacing (English)

1 reference

29 August 2017

Reginald Liew

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

page(s)

1398-1407

1 reference

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Atrial fibrillation and death after myocardial infarction: a community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Lenient versus strict rate control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patien

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Right ventricular function and survival following cardiac resynchronisation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Cardiac-resynchronization therapy for the prevention of heart-failure events

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Does ventricular dyssynchrony on echocardiography predict response to cardiac resynchronisation therapy? A randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Adenosine plasma level and A2A adenosine receptor expression: correlation with laboratory tests in patients with neurally mediated syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Prognosis among healthy individuals discharged with a primary diagnosis of syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Sudden Death in Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Nationwide study of sudden cardiac death in persons aged 1-35 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Risk factors for sudden cardiac death in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Sudden cardiac arrest associated with early repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Long-term outcome associated with early repolarization on electrocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Prevalence of J-point elevation in sudden arrhythmic death syndrome families

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Identification of large families in early repolarization syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Early repolarisation: controversies and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Clinical significance of variants of J-points and J-waves: early repolarization patterns and risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Sudden death and ion channel disease: pathophysiology and implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Genetics and cardiovascular disease--causes and prevention of unexpected sudden adult death: the role of the SADS clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Intracardiac electrogram T-wave alternans/variability increases before spontaneous ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients: a prospective, multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Sprint Fidelis lead fractures in patients with cardiac resynchronization therapy devices: insight from the Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Preventing Overdiagnosis of Implantable Cardioverter-Defibrillator Lead Fractures Using Device Diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Infrequent physician use of implantable cardioverter-defibrillators risks patient safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Out-of-hospital cardiac arrest: recent advances in resuscitation and effects on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Advances in the hospital management of patients following an out of hospital cardiac arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Increases in survival from out-of-hospital cardiac arrest: a five year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Increase in survival and bystander CPR in out-of-hospital shockable arrhythmia: bystander CPR and female gender are predictors of improved outcome. Experiences from Sweden in an 18-year perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Ventricular tachyarrhythmias after cardiac arrest in public versus at home

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children. A comprehensive, prospective, population-based study in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Chest compressions before defibrillation for out-of-hospital cardiac arrest: a meta-analysis of randomized controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Conventional and chest-compression-only cardiopulmonary resuscitation by bystanders for children who have out-of-hospital cardiac arrests: a prospective, nationwide, population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Outcomes of chest compression only CPR versus conventional CPR conducted by lay people in patients with out of hospital cardiopulmonary arrest witnessed by bystanders: nationwide population based observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

Pericardial Fat Is Associated With Atrial Fibrillation Severity and Ablation Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

10.1136/HEARTJNL-2013-304592

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference